Zydus Lifesciences' Liquid Medicine For Treatment Of Severe Inherited Muscular Dystrophy Receives Final Approval From US Health Regulator
Published on: Oct. 7, 2025, 11:33 a.m. | Source: Free Press Journal
The approval by the US Food and Drug Administration (USFDA) is for Deflazacort oral suspension of strength 22.75 mg/ml, Zydus Lifesciences Ltd said in a regulatory filing.
